Detalhe da pesquisa
1.
Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome.
Crit Care Med
; 50(12): 1701-1713, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36226977
2.
Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival.
J Heart Lung Transplant
; 29(8): 865-72, 2010 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-20466565